A 46-Year-Old Man Is Currently Enrolled In A Phase 2 Study Of A Drug For Severe Diabetic Neuropathy. While The Study Is On-Going, A New Drug Becomes Commercially Available That May Have Equal Or Greater Benefit To The Subject. The Investigator Should Do Which Of The Following?. A new drug becomes available that may have equal or greater benefit. While the study is on going, a new drug becomes commercially available that may.

While the study is on going, a new drug becomes commercially available that may. The investigator must ensure that the subject is fully informed about the new drug, including its benefits, potential side. A set of flashcards to test your knowledge of informed consent in research, including a scenario about a phase 2 study of a drug for diabetic neuropathy.